Weiss L - Search Results

1

Immunotherapy of murine leukemia following non-myeloablative conditioning with naïve or G-CSF mobilized blood or bone marrow stem cells.

Weiss L, Or R, Slavin S, Naparstek E, Reich S, Abdul-Hai A. Weiss L, et al. Cancer Immunol Immunother. 2004 Apr;53(4):358-62. doi: 10.1007/s00262-003-0440-5. Epub 2003 Nov 5. Cancer Immunol Immunother. 2004. PMID: 14605765 Free PMC article.

2

Donor lymphocyte infusion: the use of alloreactive and tumor-reactive lymphocytes for immunotherapy of malignant and nonmalignant diseases in conjunction with allogeneic stem cell transplantation.

Slavin S, Morecki S, Weiss L, Or R. Slavin S, et al. Among authors: weiss l. J Hematother Stem Cell Res. 2002 Apr;11(2):265-76. doi: 10.1089/152581602753658457. J Hematother Stem Cell Res. 2002. PMID: 11983098 Review.

3

Linomide administration following bone marrow transplantation in mice.

Weiss L, Abdul-Hai A, Shufaro Y, Reich S, Slavin S. Weiss L, et al. Cancer Immunol Immunother. 2002 Dec;51(11-12):596-602. doi: 10.1007/s00262-002-0311-5. Epub 2002 Sep 27. Cancer Immunol Immunother. 2002. PMID: 12439604 Free PMC article.

4

Immunotherapy of hematologic malignancies and metastatic solid tumors in experimental animals and man.

Slavin S, Morecki S, Weiss L, Or R. Slavin S, et al. Among authors: weiss l. Crit Rev Oncol Hematol. 2003 May;46(2):139-63. doi: 10.1016/s1040-8428(02)00108-7. Crit Rev Oncol Hematol. 2003. PMID: 12711359 Review.

5

Nonmyeloablative stem cell transplantation: reduced-intensity conditioning for cancer immunotherapy--from bench to patient bedside.

Slavin S, Morecki S, Weiss L, Shapira MY, Resnick I, Or R. Slavin S, et al. Among authors: weiss l. Semin Oncol. 2004 Feb;31(1):4-21. doi: 10.1053/j.seminoncol.2003.10.016. Semin Oncol. 2004. PMID: 14970932 Review.

6

Mycophenolate mofetil does not suppress the graft-versus-leukemia effect or the activity of lymphokine-activated killer (LAK) cells in a murine model.

Shapira MY, Hirshfeld E, Weiss L, Zeira M, Kasir J, Or R, Resnick IB, Slavin S. Shapira MY, et al. Among authors: weiss l. Cancer Immunol Immunother. 2005 Apr;54(4):383-8. doi: 10.1007/s00262-004-0614-9. Epub 2004 Nov 3. Cancer Immunol Immunother. 2005. PMID: 15692848 Free PMC article.

7

Induction of early post-transplant graft-versus-leukemia effects using intentionally mismatched donor lymphocytes and elimination of alloantigen-primed donor lymphocytes for prevention of graft-versus-host disease.

Yang I, Weiss L, Abdul-Hai A, Kasir J, Reich S, Slavin S. Yang I, et al. Among authors: weiss l. Cancer Res. 2005 Nov 1;65(21):9735-40. doi: 10.1158/0008-5472.CAN-04-4175. Cancer Res. 2005. PMID: 16266994

8

Improved survival following induction of GVHD following lipopolysaccharide immunization.

Abdul-Hai A, Weiss L, Slavin S, Or R. Abdul-Hai A, et al. Among authors: weiss l. Exp Hematol. 2006 Apr;34(4):549-53. doi: 10.1016/j.exphem.2006.01.004. Exp Hematol. 2006. PMID: 16569601 Free article.

9

N-acetylcysteine mildly inhibits the graft-vs.-leukemia effect but not the lymphokine activated cells (LAK) activity.

Weiss L, Reich S, Zeira M, Or R, Resnick IB, Slavin S, Shapira MY. Weiss L, et al. Transpl Immunol. 2007 Apr;17(3):198-202. doi: 10.1016/j.trim.2006.10.005. Epub 2006 Nov 28. Transpl Immunol. 2007. PMID: 17331847

10

Enhanced marrow recovery by short preincubation of marrow allografts with human recombinant interleukin-3 and granulocyte-macrophage colony-stimulating factor.

Naparstek E, Hardan Y, Ben-Shahar M, Nagler A, Or R, Mumcuoglu M, Weiss L, Samuel S, Slavin S. Naparstek E, et al. Among authors: weiss l. Blood. 1992 Oct 1;80(7):1673-8. Blood. 1992. PMID: 1391938 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,050 results

Search Page

Filters